US4844732A
(en)
|
1985-10-24 |
1989-07-04 |
Daicel Chemical Industries Ltd. |
Pyridine-3-carboxamide derivatives
|
JPH075555B2
(ja)
|
1986-02-25 |
1995-01-25 |
ダイセル化学工業株式会社 |
ピリドン−3−カルボキサミドの製法
|
JPH075554B2
(ja)
|
1986-02-25 |
1995-01-25 |
ダイセル化学工業株式会社 |
5−ブロモピリドン−3−カルボキサミド化合物の製法
|
KR920701167A
(ko)
|
1989-07-07 |
1992-08-11 |
에릭 에스. 딕커 |
약제학적 활성 화합물
|
US5304121A
(en)
|
1990-12-28 |
1994-04-19 |
Boston Scientific Corporation |
Drug delivery system making use of a hydrogel polymer coating
|
MY106399A
(en)
|
1990-07-24 |
1995-05-30 |
Pfizer |
Cephalosporins and homologeus, preparation and pharmaceutical composition
|
FR2665440B1
(fr)
|
1990-07-31 |
1994-02-04 |
Lipha |
Nouveaux cycloalkylsulfonamides substitues, procedes de preparation et medicaments les contenant.
|
JPH05107574A
(ja)
|
1991-03-12 |
1993-04-30 |
Mitsui Petrochem Ind Ltd |
有機非線形光学材料
|
AU676993B2
(en)
|
1991-06-27 |
1997-04-10 |
Virginia Commonwealth University |
Sigma receptor ligands and the use thereof
|
US5356897A
(en)
|
1991-09-09 |
1994-10-18 |
Fujisawa Pharmaceutical Co., Ltd. |
3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines
|
IT1254134B
(it)
|
1992-01-16 |
1995-09-08 |
Angeletti P Ist Richerche Bio |
Oligonucleotidi antisenso chimicamente modificati.
|
EP0558245A1
(en)
|
1992-02-25 |
1993-09-01 |
RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY |
Heterobicyclic compounds as antagogists of alpha-1 adrenergic and SHT1A receptors
|
IT1254469B
(it)
|
1992-02-25 |
1995-09-25 |
Recordati Chem Pharm |
Derivati benzopiranici e benzotiopiranici
|
DE69327536T2
(de)
|
1992-10-14 |
2000-07-06 |
Merck & Co Inc |
Fibrinogenrezeptor-antagonisten
|
US5994341A
(en)
|
1993-07-19 |
1999-11-30 |
Angiogenesis Technologies, Inc. |
Anti-angiogenic Compositions and methods for the treatment of arthritis
|
US6099562A
(en)
|
1996-06-13 |
2000-08-08 |
Schneider (Usa) Inc. |
Drug coating with topcoat
|
GB2300856A
(en)
|
1995-05-16 |
1996-11-20 |
Pfizer Ltd |
Beta-lactam preparation
|
JP3964478B2
(ja)
|
1995-06-30 |
2007-08-22 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
ヘテロ環含有カルボン酸誘導体及びそれを含有する医薬
|
AU4153496A
(en)
|
1995-10-20 |
1997-05-07 |
Flora Inc. |
Transdermal delivery of alpha adrenoceptor blocking agents
|
WO1997027852A1
(en)
|
1996-01-30 |
1997-08-07 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US5968965A
(en)
|
1996-01-30 |
1999-10-19 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
FR2746309B1
(fr)
|
1996-03-22 |
1998-04-17 |
Oreal |
Composition de teinture des fibres keratiniques contenant des pyrazolopyrimidineoxo ; leur utilisation pour la teinture comme coupleurs, procedes de teinture
|
IL129126A0
(en)
|
1996-10-16 |
2000-02-17 |
Icn Pharmaceuticals |
Monocyclic l-nucleosides analogs and uses thereof
|
CA2268399C
(en)
|
1996-10-31 |
2008-08-19 |
Harbor Branch Oceanographic Institution, Inc. |
Anti-neurogenic inflammatory compounds and compositions and methods of use thereof
|
JPH10213820A
(ja)
|
1997-01-31 |
1998-08-11 |
Canon Inc |
液晶素子及び液晶装置
|
US5942508A
(en)
|
1997-02-04 |
1999-08-24 |
Senju Pharmaceutical Co., Ltd. |
Method for solubilizing pyridonecarboxylic acid solubilizer thereof and aqueous solution containing solubilized pyridonecarboxylic acid
|
CA2307613A1
(en)
|
1997-10-22 |
1999-04-29 |
Eisai Co., Ltd. |
Retinoic acid agonist as a prophylactic and therapeutic agent for nephritis
|
US6150379A
(en)
|
1997-11-26 |
2000-11-21 |
Axys Pharmaceuticals, Inc. |
Compounds and compositions as anticoagulants
|
AU6060099A
(en)
|
1998-09-30 |
2000-04-17 |
Procter & Gamble Company, The |
2-substituted ketoamides
|
WO2000025789A1
(en)
|
1998-10-29 |
2000-05-11 |
Merck & Co., Inc. |
A method of treating endometriosis
|
SK15522001A3
(sk)
|
1999-04-28 |
2002-06-04 |
Aventis Pharma Deutschland Gmbh |
Deriváty kyselín s tromi arylovými zvyškami ako ligandy receptorov PPAR a farmaceutické kompozície, ktoré ich obsahujú
|
WO2001012183A1
(en)
|
1999-08-16 |
2001-02-22 |
Merck & Co., Inc. |
Heterocycle amides as cell adhesion inhibitors
|
TR200201413T2
(tr)
|
1999-09-17 |
2003-02-21 |
Millennium Pharmaceuticals, Inc. |
Faktör Xa' nın inhibitörleri.
|
EP1216228B1
(en)
|
1999-09-17 |
2008-10-29 |
Millennium Pharmaceuticals, Inc. |
BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
|
EP1224197A1
(en)
|
1999-10-29 |
2002-07-24 |
Pfizer Products Inc. |
Hygromycin derivatives
|
PL200167B1
(pl)
|
1999-11-05 |
2008-12-31 |
Sod Conseils Rech Applic |
Związki heterocykliczne o aktywności hamowania kalpain i/lub pułapkowania ROS, ich zastosowanie i kompozycje farmaceutyczne je zawierające oraz związki pośrednie
|
TWI284639B
(en)
|
2000-01-24 |
2007-08-01 |
Shionogi & Co |
A compound having thrombopoietin receptor agonistic effect
|
EP1259485B1
(en)
|
2000-02-29 |
2005-11-30 |
Millennium Pharmaceuticals, Inc. |
BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
|
IL151517A0
(en)
|
2000-03-09 |
2003-04-10 |
Aventis Pharma Gmbh |
Therapeutic uses of ppar mediators
|
AU2001275881B2
(en)
|
2000-07-10 |
2006-04-06 |
Vertex Pharmaceuticals (San Diego) Llc |
Ion channel assay methods
|
BR0113697A
(pt)
|
2000-09-06 |
2003-07-22 |
Neurogen Corp |
Composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de um composto ou sal, embalagem e métodos para, para alterar a atividade transdutora de sinal dos receptores de gabaa, para tratar ansiedade, depressão, um distúrbio do sono, ou demência de alzheimer, para demonstrar a presença dos receptores de gabaa em células ou amostras de tecido e para preparar um composto
|
AU2002255473A1
(en)
|
2000-10-24 |
2002-09-04 |
Glaxo Group Limited |
Process for preparing intermediates of hiv protease inhibitors
|
JP3786203B2
(ja)
|
2000-11-04 |
2006-06-14 |
アベンティス・フアーマ・リミテッド |
置換アルカン酸
|
EP1217000A1
(en)
|
2000-12-23 |
2002-06-26 |
Aventis Pharma Deutschland GmbH |
Inhibitors of factor Xa and factor VIIa
|
IL156595A0
(en)
|
2001-01-16 |
2004-01-04 |
Astrazeneca Ab |
Therapeutic heterocyclic compounds
|
WO2002070483A1
(en)
|
2001-03-05 |
2002-09-12 |
E. I. Du Pont De Nemours And Company |
Heterocyclic diamide invertebrate pest control agents
|
WO2002083628A1
(en)
|
2001-04-13 |
2002-10-24 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
1,4-disubstituted benzo-fused compounds
|
JP2003034671A
(ja)
|
2001-05-17 |
2003-02-07 |
Nippon Nohyaku Co Ltd |
ベンズアミド誘導体及び農園芸用薬剤並びにその使用方法
|
US20030175950A1
(en)
|
2001-05-29 |
2003-09-18 |
Mcswiggen James A. |
RNA interference mediated inhibition of HIV gene expression using short interfering RNA
|
WO2003070912A2
(en)
|
2001-06-06 |
2003-08-28 |
Sirna Therapeutics, Inc. |
RNA INTERFERENCE MEDIATED INHIBITION OF EPIDERMAL GROWTH FACTOR RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
US20050080112A1
(en)
|
2001-06-22 |
2005-04-14 |
Madsen Lars Siim |
Compounds for use in disorders associated with mast cell or basophil acitvity
|
CH1427415H1
(de)
|
2001-09-21 |
2023-12-21 |
Bristol Myers Squibb Holdings Ireland |
Lactamhaltige verbindungen und ihre derivate als faktor-xa-hemmer
|
FR2831536A1
(fr)
|
2001-10-26 |
2003-05-02 |
Aventis Pharma Sa |
Nouveaux derives de benzimidazoles, leur procede de preparation, leur application a titre de medicament, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de kdr
|
SE0103648D0
(sv)
|
2001-11-01 |
2001-11-01 |
Astrazeneca Ab |
Therapeutic quinolone compounds
|
AU2002344567A1
(en)
|
2001-11-28 |
2003-06-10 |
Daiso Co., Ltd. |
Heterocyclic amide compounds as apolipoprotein b inhibitors
|
WO2003048081A2
(en)
|
2001-12-04 |
2003-06-12 |
Bristol-Myers Squibb Company |
Glycinamides as factor xa inhibitors
|
EP1467985A1
(en)
|
2002-01-22 |
2004-10-20 |
E.I. Du Pont De Nemours And Company |
Diamide invertebrate pest control agents
|
EP1336602A1
(en)
|
2002-02-13 |
2003-08-20 |
Giovanni Scaramuzzino |
Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases
|
US7067540B2
(en)
|
2002-02-14 |
2006-06-27 |
Pharmacia Corporation |
Substituted pyridinones
|
EP1490058B1
(en)
|
2002-02-21 |
2007-10-10 |
Eli Lilly And Company |
Peroxisome proliferator activated receptor modulators
|
AU2003217863B9
(en)
|
2002-02-28 |
2009-10-29 |
Biota Scientific Management Pty Ltd |
Nucleotide mimics and their prodrugs
|
WO2003101381A2
(en)
*
|
2002-05-29 |
2003-12-11 |
Merck & Co., Inc. |
1,2 diamido cycloalkyl sodium channel blockers
|
JP2006513159A
(ja)
|
2002-11-01 |
2006-04-20 |
メルク エンド カムパニー インコーポレーテッド |
アンドロゲン受容体モジュレーターとしてのカルボニルアミノ−ベンズイミダゾール誘導体
|
EP1581539A4
(en)
|
2003-01-03 |
2007-09-19 |
Bristol Myers Squibb Co |
NEW TYROSINE KINASE HEMMER
|
KR101145252B1
(ko)
|
2003-01-08 |
2012-05-24 |
유니버시티 오브 워싱톤 |
항균제
|
US7122557B2
(en)
|
2003-03-18 |
2006-10-17 |
Bristol-Myers Squibb Company |
Sulfonyl-amidino-containing and tetrahydropyrimidino-containing compounds as factor Xa inhibitors
|
US7365178B2
(en)
|
2003-04-01 |
2008-04-29 |
Activx Biosciences, Inc. |
Acyl-nucleotide probes and methods of their synthesis and use in proteomic analysis
|
EP1613261A4
(en)
|
2003-04-09 |
2011-01-26 |
Novo Nordisk As |
INTRA-CELLULAR FORMATION OF PEPTIDE CONJUGATES
|
US20040229839A1
(en)
|
2003-05-14 |
2004-11-18 |
Biocryst Pharmaceuticals, Inc. |
Substituted nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
|
CA2528438A1
(en)
|
2003-06-03 |
2005-01-06 |
Novartis Ag |
P-38 inhibitors
|
GB0315111D0
(en)
|
2003-06-27 |
2003-07-30 |
Cancer Rec Tech Ltd |
Substituted 5-membered ring compounds and their use
|
WO2005000309A2
(en)
|
2003-06-27 |
2005-01-06 |
Ionix Pharmaceuticals Limited |
Chemical compounds
|
EP1673357A2
(en)
|
2003-08-08 |
2006-06-28 |
Vertex Pharmaceuticals Incorporated |
Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
|
JP2007502778A
(ja)
|
2003-08-21 |
2007-02-15 |
グリフィス ユニバーシティ |
新規スルフェンアミドオキシド
|
MXPA06001976A
(es)
|
2003-08-21 |
2006-05-31 |
Univ Griffith |
Nuevas sulfenamidas.
|
MXPA06002198A
(es)
|
2003-08-27 |
2007-08-14 |
Biota Scient Management |
Nucleosidos o nucleotidos triciclicos novedosos como agentes terapeuticos.
|
EP1669348A4
(en)
|
2003-09-30 |
2009-03-11 |
Eisai R&D Man Co Ltd |
NEW ANTIPILIC AGENT CONTAINING A HETEROCYCLIC COMPOUND
|
GB0325956D0
(en)
|
2003-11-06 |
2003-12-10 |
Addex Pharmaceuticals Sa |
Novel compounds
|
JP4526801B2
(ja)
|
2003-11-13 |
2010-08-18 |
新日鐵化学株式会社 |
複素環化合物の製造方法
|
EP1532980A1
(en)
|
2003-11-24 |
2005-05-25 |
Novo Nordisk A/S |
N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
|
MXPA06005882A
(es)
|
2003-11-25 |
2006-06-27 |
Pfizer Prod Inc |
Metodo de tratamiento de la aterosclerosis.
|
EP1802580A2
(en)
|
2004-07-23 |
2007-07-04 |
Pfizer, Inc. |
Pyridine derivatives
|
AU2005274681A1
(en)
|
2004-08-16 |
2006-02-23 |
Verva Pharmaceuticals Pty Ltd |
Metabolism-modulating agents and uses therefor
|
AU2005282761B2
(en)
|
2004-09-02 |
2012-02-02 |
Vertex Pharmaceuticals Incorporated |
Quinazolines useful as modulators of ion channels
|
US8802840B2
(en)
|
2005-03-08 |
2014-08-12 |
Biota Scientific Management Pty Ltd. |
Bicyclic nucleosides and nucleotides as therapeutic agents
|
WO2006113615A2
(en)
|
2005-04-15 |
2006-10-26 |
Sloan-Kettering Institute For Cancer Research |
Anti-microbial agents and uses thereof
|
CN101175718A
(zh)
|
2005-05-09 |
2008-05-07 |
沃泰克斯药物股份有限公司 |
制备联芳基脲及其类似物的方法
|
WO2006124780A2
(en)
|
2005-05-12 |
2006-11-23 |
Kalypsys, Inc. |
Ih-benzo [d] imidazole compounds as inhibitors of b-raf kinase
|
GB0510141D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B3
|
EP1891039A1
(en)
|
2005-05-20 |
2008-02-27 |
Vertex Pharmaceuticals Incorporated |
Quinoline derivatives useful as modulators of ion channels
|
EP1904491A2
(en)
|
2005-05-31 |
2008-04-02 |
Vertex Pharmaceuticals Incorporated |
Heterocycles useful as modulators of ion channels
|
JP2007056213A
(ja)
|
2005-08-26 |
2007-03-08 |
Fujifilm Corp |
焼結含油軸受油用組成物、並びにそれを用いた軸受け装置及び摺動部材
|
DK1954697T3
(da)
|
2005-10-21 |
2010-06-14 |
Glaxo Group Ltd |
Peri-kondenserede tricykliske forbindelser, der er anvendelige som antibakterielle midler
|
WO2007052843A1
(ja)
|
2005-11-04 |
2007-05-10 |
Takeda Pharmaceutical Company Limited |
複素環アミド化合物およびその用途
|
WO2007081966A2
(en)
|
2006-01-09 |
2007-07-19 |
University Of Southern California |
Small molecules for treating cancer and abnormal cell proliferation disorders
|
UY30118A1
(es)
|
2006-01-31 |
2007-06-29 |
Tanabe Seiyaku Co |
Compueto amina trisustituido
|
US9155792B2
(en)
|
2006-02-13 |
2015-10-13 |
Trustees Of Boston University |
RecA inhibitors with antibiotic activity, compositions and methods of use
|
AR059826A1
(es)
|
2006-03-13 |
2008-04-30 |
Univ California |
Inhibidores de urea conformacionalmente restringidos de epoxido hidrolasa soluble
|
US7480400B2
(en)
|
2006-03-16 |
2009-01-20 |
Siemens Medical Solutions Usa, Inc. |
Detection of fiber pathways
|
MX2008013194A
(es)
|
2006-04-11 |
2008-12-01 |
Vertex Pharma |
Composiciones utiles como inhibidores de canales de sodio regulados por voltaje.
|
AU2007257959A1
(en)
|
2006-06-09 |
2007-12-21 |
Kemia, Inc. |
Therapy using cytokine inhibitors
|
WO2008001195A2
(en)
|
2006-06-27 |
2008-01-03 |
Glenmark Pharmaceuticals S.A. |
Novel processes for the preparation of dpp iv inhibitors
|
WO2008005542A2
(en)
|
2006-07-07 |
2008-01-10 |
Gilead Sciences, Inc., |
Antiviral phosphinate compounds
|
PE20080948A1
(es)
|
2006-07-25 |
2008-09-10 |
Irm Llc |
Derivados de imidazol como moduladores de la senda de hedgehog
|
EP1882475A1
(en)
|
2006-07-26 |
2008-01-30 |
Novartis AG |
Method of treating disorders mediated by the fibroblast growth factor receptor
|
AU2007281993B2
(en)
|
2006-08-08 |
2013-08-29 |
Millennium Pharmaceuticals, Inc. |
Heteroaryl compounds useful as inhibitors of E1 activating enzymes
|
WO2008018129A1
(fr)
|
2006-08-09 |
2008-02-14 |
Shinichiro Isobe |
Procédé de détection de protéine et colorant fluorescent utilisé à cet effet
|
CA2663147A1
(en)
|
2006-09-11 |
2008-03-20 |
Curis, Inc. |
Substituted 2-indolinone as ptk inhibitors containing a zinc binding moiety
|
KR101433629B1
(ko)
|
2006-09-11 |
2014-08-27 |
쿠리스 인코퍼레이션 |
아연 결합 부분을 함유한 티로신 키나아제 억제제
|
US8466188B2
(en)
|
2006-10-12 |
2013-06-18 |
Xenon Pharmaceuticals Inc. |
Use of spiro-oxindole compounds as therapeutic agents
|
CN101541759A
(zh)
|
2006-11-27 |
2009-09-23 |
诺瓦提斯公司 |
取代的二氢咪唑类及其在治疗肿瘤中的用途
|
PT2101760E
(pt)
|
2006-12-08 |
2013-05-07 |
Millennium Pharm Inc |
Formulações de dose unitária e métodos de tratamento da trombose com um inibidor oral do fator xa
|
EP2094276A4
(en)
|
2006-12-20 |
2011-01-05 |
Abbott Lab |
ANTIVIRAL COMPOUNDS
|
FR2911140B1
(fr)
|
2007-01-05 |
2009-02-20 |
Sanofi Aventis Sa |
Nouveaux derives de 2-anilino 4-heteroaryle pyrimides, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
FR2911138B1
(fr)
|
2007-01-05 |
2009-02-20 |
Sanofi Aventis Sa |
Nouveaux derives de n, n'-2,4-dianilinopyrimidines, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
FR2911139A1
(fr)
|
2007-01-05 |
2008-07-11 |
Sanofi Aventis Sa |
Nouveaux derives de phenyl-(4-phenyl-pyrimidin-2-yl)amines, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
WO2008094507A2
(en)
|
2007-01-26 |
2008-08-07 |
Cellicon Biotechnologies, Inc. |
Novel fusion compounds
|
US20080234332A1
(en)
|
2007-03-20 |
2008-09-25 |
Xiong Cai |
Raf kinase inhibitors containing a zinc binding moiety
|
US20080234297A1
(en)
|
2007-03-20 |
2008-09-25 |
Changgeng Qian |
HSP90 Inhibitors Containing a Zinc Binding Moiety
|
KR20100007956A
(ko)
*
|
2007-05-03 |
2010-01-22 |
화이자 리미티드 |
나트륨 채널 조절제로서의 2-피리딘 카복스아마이드 유도체
|
WO2008156783A2
(en)
|
2007-06-18 |
2008-12-24 |
University Of Louisville Research Foundation, Inc. |
Family of pfkfb3 inhibitors with anti-neoplastic activities
|
JP5492770B2
(ja)
|
2007-06-26 |
2014-05-14 |
サノフイ |
ベンゾイミダゾール及びアザベンゾイミダゾールの位置選択的銅触媒合成
|
UA105758C2
(uk)
|
2007-07-19 |
2014-06-25 |
Х. Луннбек А/С |
5-членні гетероциклічні аміди та споріднені сполуки
|
JP4834699B2
(ja)
|
2007-07-30 |
2011-12-14 |
田辺三菱製薬株式会社 |
医薬組成物
|
JP4846769B2
(ja)
|
2007-07-30 |
2011-12-28 |
田辺三菱製薬株式会社 |
医薬組成物
|
FR2919869B1
(fr)
|
2007-08-09 |
2009-09-25 |
Sanofi Aventis Sa |
Nouveaux derives de n, n'-2,4-dianilinopyrimidines, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
WO2009036051A1
(en)
|
2007-09-10 |
2009-03-19 |
Curis, Inc. |
Bcl-2 inhibitors containing a zinc binding moiety
|
TW200920357A
(en)
|
2007-09-10 |
2009-05-16 |
Curis Inc |
HSP90 inhibitors containing a zinc binding moiety
|
WO2009036066A1
(en)
|
2007-09-10 |
2009-03-19 |
Curis, Inc. |
Vegfr inhibitors containing a zinc binding moiety
|
CN101801933A
(zh)
|
2007-09-26 |
2010-08-11 |
安斯泰来制药株式会社 |
喹诺酮衍生物
|
EP2195304B1
(en)
|
2007-10-08 |
2014-01-08 |
Advinus Therapeutics Private Limited |
Acetamide derivatives as glucokinase activators, their process and medicinal applications
|
CA2701766A1
(en)
|
2007-10-11 |
2009-04-16 |
Vertex Pharmaceuticals Incorporated |
Amides useful as inhibitors of voltage-gated sodium channels
|
AU2008310663A1
(en)
|
2007-10-11 |
2009-04-16 |
Vertex Pharmaceuticals Incorporated |
Aryl amides useful as inhibitors of voltage-gated sodium channels
|
US8519137B2
(en)
|
2007-10-11 |
2013-08-27 |
Vertex Pharmaceuticals Incorporated |
Heteroaryl amides useful as inhibitors of voltage-gated sodium channels
|
WO2009069132A2
(en)
|
2007-11-29 |
2009-06-04 |
Ramot At Tel Aviv University Ltd. |
Novel reverse transcriptase inhibitors
|
EP2231671B1
(en)
|
2007-12-13 |
2013-04-24 |
Vertex Pharmaceuticals Incorporated |
Modulators of cystic fibrosis transmembrane conductance regulator
|
JP2011507910A
(ja)
|
2007-12-21 |
2011-03-10 |
ユニバーシティー オブ ロチェスター |
真核生物の寿命を変更するための方法
|
US20110046199A1
(en)
|
2008-01-17 |
2011-02-24 |
Purdue Research Foundation |
Small molecule inhibitors of hiv proteases
|
US20120108630A1
(en)
|
2008-02-12 |
2012-05-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Hedgehog Pathway Antagonists and Methods of Use
|
WO2009114470A2
(en)
|
2008-03-10 |
2009-09-17 |
Curis, Inc. |
Tetrahydroindole and tetrahdyroindazole as hsp90 inhibitors containing a zinc binding moiety
|
JP5219583B2
(ja)
|
2008-03-31 |
2013-06-26 |
住友化学株式会社 |
組成物、光学フィルムとその製造方法、光学部材及び表示装置
|
PE20091838A1
(es)
|
2008-04-09 |
2009-12-18 |
Infinity Pharmaceuticals Inc |
Inhibidores de amida hidrolasa de acido graso
|
US9029408B2
(en)
|
2008-06-16 |
2015-05-12 |
Gtx, Inc. |
Compounds for treatment of cancer
|
DK2959900T3
(en)
|
2008-06-16 |
2017-06-26 |
Univ Tennessee Res Found |
CONNECTION TO TREATMENT OF CANCER
|
EP2315763B1
(en)
|
2008-07-03 |
2016-06-01 |
Glaxosmithkline LLC |
Benzimidazoles and related analogs as sirtuin modulators
|
JP5443720B2
(ja)
|
2008-09-05 |
2014-03-19 |
住友化学株式会社 |
組成物、光学フィルム及びその製造方法、光学部材ならびに表示装置
|
WO2010027512A2
(en)
|
2008-09-06 |
2010-03-11 |
Chemgenes Corporation |
Rna synthesis - phosphoramidites for synthetic rna in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic rna at the 3' - end
|
US8541569B2
(en)
|
2008-09-06 |
2013-09-24 |
Chemgenes Corporation |
Phosphoramidites for synthetic RNA in the reverse direction, efficient RNA synthesis and convenient introduction of 3'-end ligands, chromophores and modifications of synthetic RNA
|
ES2398342T3
(es)
|
2008-09-18 |
2013-03-15 |
F. Hoffmann-La Roche Ag |
Pirrolidina-2-carboxamidas sustituidas
|
US8354444B2
(en)
|
2008-09-18 |
2013-01-15 |
Hoffmann-La Roche Inc. |
Substituted pyrrolidine-2-carboxamides
|
EP2342188B1
(en)
|
2008-09-29 |
2014-07-30 |
GlaxoSmithKline LLC |
Chromenone analogs as sirtuin modulators
|
WO2010048149A2
(en)
|
2008-10-20 |
2010-04-29 |
Kalypsys, Inc. |
Heterocyclic modulators of gpr119 for treatment of disease
|
EP2184273A1
(de)
|
2008-11-05 |
2010-05-12 |
Bayer CropScience AG |
Halogen-substituierte Verbindungen als Pestizide
|
US20120165304A1
(en)
|
2008-11-27 |
2012-06-28 |
Boehringer Ingelheim International Gmbh |
6,7,8,9-Tetrahydro-5H-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them
|
GB0821913D0
(en)
|
2008-12-02 |
2009-01-07 |
Price & Co |
Antibacterial compounds
|
US20110237622A1
(en)
|
2008-12-10 |
2011-09-29 |
Merck Frosst Canada Ltd. |
Renin inhibitors
|
US20120040916A1
(en)
|
2008-12-22 |
2012-02-16 |
Massachusetts Institute Of Technology |
Molecular inhibitors of the wnt/beta-catenin pathway
|
JP5405592B2
(ja)
|
2008-12-23 |
2014-02-05 |
エフ.ホフマン−ラ ロシュ アーゲー |
P2x7モジュレーターとしてのジヒドロピリドンアミド
|
AU2009331179B2
(en)
|
2008-12-26 |
2014-09-18 |
Sumitomo Pharma Co., Ltd. |
Novel bicyclic heterocyclic compound
|
KR20100087540A
(ko)
|
2009-01-28 |
2010-08-05 |
삼성전자주식회사 |
잉크젯 기록용 잉크 조성물
|
CN102448458B
(zh)
|
2009-03-18 |
2015-07-22 |
小利兰·斯坦福大学理事会 |
治疗黄病毒科病毒感染的方法和组合物
|
SG10201401169QA
(en)
|
2009-04-02 |
2014-05-29 |
Merck Serono Sa |
Dihydroorotate dehydrogenase inhibitors
|
TWI638808B
(zh)
|
2009-04-28 |
2018-10-21 |
美商環球展覽公司 |
具有甲基-d3取代之銥錯合物
|
US9174999B2
(en)
|
2009-05-07 |
2015-11-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions for studying, imaging, and treating pain
|
EP2435435B1
(en)
|
2009-05-27 |
2014-01-29 |
AbbVie Inc. |
Pyrimidine inhibitors of kinase activity
|
WO2010138576A1
(en)
|
2009-05-27 |
2010-12-02 |
Abbott Laboratories |
Pyrimidine inhibitors of kinase activity
|
US9101616B2
(en)
|
2009-05-29 |
2015-08-11 |
Raqualia Pharma Inc. |
Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
|
AR077033A1
(es)
|
2009-06-11 |
2011-07-27 |
Hoffmann La Roche |
Compuestos inhibidores de las quinasas de janus y su uso en el tratamiento de enfermedades inmunologicas
|
AR077252A1
(es)
|
2009-06-29 |
2011-08-10 |
Xenon Pharmaceuticals Inc |
Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
|
WO2011005860A2
(en)
|
2009-07-07 |
2011-01-13 |
Alnylam Pharmaceuticals, Inc. |
5' phosphate mimics
|
US8629149B2
(en)
|
2009-09-04 |
2014-01-14 |
Zalicus Pharmaceuticals Ltd. |
Oxopiperazine derivatives for the treatment of pain and epilepsy
|
WO2011032169A2
(en)
|
2009-09-14 |
2011-03-17 |
Phusis Therapeutics Inc. |
Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same
|
WO2011037731A1
(en)
|
2009-09-25 |
2011-03-31 |
Anacor Pharmaceuticals, Inc. |
Boron containing small molecules
|
WO2011047320A2
(en)
|
2009-10-16 |
2011-04-21 |
Rib-X Pharmaceuticals, Inc. |
Antimicrobial compounds and methods of making and using the same
|
WO2011103196A1
(en)
*
|
2010-02-17 |
2011-08-25 |
Amgen Inc. |
Aryl carboxamide derivatives as sodium channel inhibitors for treatment of pain
|
EP3064204A1
(en)
|
2010-03-01 |
2016-09-07 |
GTx, Inc. |
Compounds for treatment of cancer
|
US11084811B2
(en)
|
2010-03-01 |
2021-08-10 |
Oncternal Therapeutics, Inc. |
Compounds for treatment of cancer
|
WO2011140425A1
(en)
|
2010-05-06 |
2011-11-10 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
|
AU2011251622A1
(en)
|
2010-05-10 |
2012-12-20 |
Radikal Therapeutics Inc. |
Lipoic acid and nitroxide derivatives and uses thereof
|
WO2011151619A1
(en)
|
2010-06-01 |
2011-12-08 |
Summit Corporation Plc |
Compounds for the treatment of clostridium difficile associated disease
|
US20120010235A1
(en)
|
2010-07-12 |
2012-01-12 |
Xin-Jie Chu |
N-substituted pyrrolidines
|
US9120752B2
(en)
*
|
2010-07-16 |
2015-09-01 |
Purdue Pharma, L.P. |
Pyridine compounds as sodium channel blockers
|
WO2012016133A2
(en)
|
2010-07-29 |
2012-02-02 |
President And Fellows Of Harvard College |
Ros1 kinase inhibitors for the treatment of glioblastoma and other p53-deficient cancers
|
US9290485B2
(en)
|
2010-08-04 |
2016-03-22 |
Novartis Ag |
N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides
|
WO2012020725A1
(ja)
|
2010-08-10 |
2012-02-16 |
塩野義製薬株式会社 |
Npy y5受容体拮抗作用を有するヘテロ環誘導体
|
CN103442568A
(zh)
|
2010-10-08 |
2013-12-11 |
Abbvie公司 |
呋喃并[3,2-d]嘧啶化合物
|
GB201017315D0
(en)
|
2010-10-13 |
2010-11-24 |
Antoxis Ltd |
Compound
|
KR101458006B1
(ko)
*
|
2010-10-18 |
2014-11-04 |
라퀄리아 파마 인코포레이티드 |
Ttx-s 차단제로서의 아릴아미드 유도체
|
EP2630136A1
(en)
|
2010-10-21 |
2013-08-28 |
Universität des Saarlandes |
Selective cyp11b1 inhibitors for the treatment of cortisol dependent diseases
|
FI20106119A0
(fi)
|
2010-10-27 |
2010-10-27 |
Sirtuin Valley Oy |
Energia-aineenvaihduntaan vaikuttava koostumus
|
GB201020076D0
(en)
|
2010-11-26 |
2011-01-12 |
Liverpool School Tropical Medicine |
Antimalarial compounds
|
DK2646436T3
(en)
|
2010-11-29 |
2015-06-29 |
Pfizer |
monobactams
|
CA2820203A1
(en)
|
2010-12-13 |
2012-06-21 |
Neural Pathways, Llc |
Handheld emg stimulator device with adjustable shaft length
|
EP2651405A2
(en)
|
2010-12-14 |
2013-10-23 |
Electrophoretics Limited |
Casein kinase 1 (ck1 ) inhibitors
|
TWI574687B
(zh)
|
2011-01-03 |
2017-03-21 |
古利斯股份有限公司 |
具有鋅結合部份之刺蝟拮抗劑
|
WO2012097330A2
(en)
|
2011-01-14 |
2012-07-19 |
University Of Washington |
Compositions and methods for treating degenerative muscle conditions
|
WO2012106534A2
(en)
|
2011-02-02 |
2012-08-09 |
The Regents Of The University Of California |
Hiv integrase inhibitors
|
PT2670752E
(pt)
|
2011-02-02 |
2016-06-14 |
Vertex Pharma |
Piperidinamidas pirrolopirazina-espirocíclicas como moduladores de canais iónicos
|
JP2012167027A
(ja)
|
2011-02-10 |
2012-09-06 |
Shionogi & Co Ltd |
Npyy5受容体拮抗作用を有する縮合ヘテロ環誘導体
|
WO2012112743A1
(en)
|
2011-02-18 |
2012-08-23 |
Vertex Pharmaceuticals Incorporated |
Chroman - spirocyclic piperidine amides as modulators of ion channels
|
WO2012116440A1
(en)
|
2011-03-03 |
2012-09-07 |
Zalicus Pharmaceuticals Ltd. |
Benzimidazole inhibitors of the sodium channel
|
MX347982B
(es)
|
2011-03-14 |
2017-05-22 |
Vertex Pharma |
Morfolina-piperidina espirociclica-amidas como moduladores de canales ionicos.
|
KR20140015472A
(ko)
|
2011-03-15 |
2014-02-06 |
애브비 인코포레이티드 |
핵 호르몬 수용체 조절제
|
WO2012129562A2
(en)
|
2011-03-24 |
2012-09-27 |
The Scripps Research Institute |
Compounds and methods for inducing chondrogenesis
|
JP5866100B2
(ja)
|
2011-04-13 |
2016-02-17 |
住友化学株式会社 |
レジスト組成物及びレジストパターンの製造方法
|
AU2012253339B2
(en)
|
2011-05-11 |
2016-03-31 |
Sanofi |
Spiro-oxindole MDM2 antagonists
|
WO2012166951A1
(en)
|
2011-05-31 |
2012-12-06 |
Receptos, Inc. |
Novel glp-1 receptor stabilizers and modulators
|
US20140094465A1
(en)
|
2011-06-10 |
2014-04-03 |
N30 Pharmaceuticals, Inc. |
Compounds as S-Nitrosoglutathione Reductase Inhibitors
|
US8822469B2
(en)
|
2011-06-22 |
2014-09-02 |
Vertex Pharmaceuticals Incorporated |
Pyrrolo[2,3-B]pyrazines useful as inhibitors of ATR kinase
|
GB201111705D0
(en)
|
2011-07-07 |
2011-08-24 |
Takeda Pharmaceutical |
Compounds and their use
|
WO2013005057A1
(en)
|
2011-07-07 |
2013-01-10 |
Centro Nacional De Investigaciones Oncológicas (Cnio) |
New compounds
|
WO2013022740A2
(en)
|
2011-08-05 |
2013-02-14 |
Corning Incorporated |
Gpr35 ligands and the uses thereof
|
SG10201606301YA
(en)
|
2011-09-12 |
2016-09-29 |
Merck Patent Gmbh |
Novel imidazole amines as modulators of kinase activity
|
US20140241990A1
(en)
|
2011-09-30 |
2014-08-28 |
Tufts University |
Methods of using adenosine a1 receptor activation for treating depression
|
EP2771335A2
(en)
|
2011-10-26 |
2014-09-03 |
Pfizer Limited |
(4-phenylimidazol-2-yl) ethylamine derivatives useful as sodium channel modulators
|
CN103159738B
(zh)
|
2011-12-19 |
2016-09-07 |
上海泓博智源医药股份有限公司 |
炔基桥连的杂芳香化合物及其应用
|
MX2014008591A
(es)
|
2012-01-16 |
2014-08-22 |
Vertex Pharma |
Piperidinamidas piranoespirociclicas como moduladores de canales de iones.
|
FR2985916B1
(fr)
|
2012-01-25 |
2015-12-04 |
Univ Bordeaux Segalen |
Decontamination par hydrogels d'echantillons aqueux contenant des nanoparticules
|
CA2861439C
(en)
|
2012-02-03 |
2016-07-12 |
Pfizer Inc. |
Benzimidazole and imidazopyridine derivatives as sodium channel modulators
|
JP6195579B2
(ja)
|
2012-02-08 |
2017-09-13 |
ノファリクス ドイチェラント ゲーエムベーハー |
アフィニティークロマトグラフィーIVによる抗体及びFc融合タンパク質精製のためのリガンド
|
JP6396216B2
(ja)
|
2012-02-22 |
2018-09-26 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung |
液晶媒体
|
WO2013131018A1
(en)
|
2012-03-02 |
2013-09-06 |
Zalicus Pharmaceuticals Ltd. |
Biaryl inhibitors of the sodium channel
|
DK2822953T5
(en)
|
2012-03-06 |
2017-09-11 |
Pfizer |
Macrocyclic derivatives for the treatment of proliferative diseases
|
JP5798066B2
(ja)
|
2012-03-08 |
2015-10-21 |
富士フイルム株式会社 |
化合物、液晶組成物、高分子材料およびフィルム
|
JP5804991B2
(ja)
|
2012-03-19 |
2015-11-04 |
富士フイルム株式会社 |
光反射フィルム、自動車用フロントガラス、建材用ガラス
|
WO2013151975A1
(en)
|
2012-04-02 |
2013-10-10 |
Northeastern University |
Compositions and methods for the inhibition of methyltransferases
|
CN107540594A
(zh)
|
2012-05-30 |
2018-01-05 |
霍夫曼-拉罗奇有限公司 |
取代的吡咯烷‑2‑甲酰胺
|
JP5867298B2
(ja)
|
2012-06-06 |
2016-02-24 |
Jsr株式会社 |
フォトレジスト組成物及びレジストパターン形成方法
|
WO2013188881A1
(en)
|
2012-06-15 |
2013-12-19 |
President And Fellows Of Harvard College |
Compounds, compositions and methods for treating or preventing neurodegenerative disorders
|
US20140005181A1
(en)
|
2012-06-21 |
2014-01-02 |
Sanford-Burnham Medical Research Institute |
Small molecule antagonists of the apelin receptor for the treatment of disease
|
WO2014003153A1
(ja)
|
2012-06-28 |
2014-01-03 |
協和発酵キリン株式会社 |
置換アミド化合物
|
US9682970B2
(en)
|
2012-06-29 |
2017-06-20 |
Biotium, Inc. |
Fluorescent compounds and uses thereof
|
US9040498B2
(en)
|
2012-07-06 |
2015-05-26 |
Research Foundation Of The City University Of New York |
1,2,3-Triazolyl purine derivatives
|
TW201416354A
(zh)
|
2012-07-17 |
2014-05-01 |
Boehringer Ingelheim Int |
白三烯生成抑制劑
|
TW201416362A
(zh)
|
2012-07-19 |
2014-05-01 |
Dainippon Sumitomo Pharma Co |
1-(環烷基羰基)脯胺酸衍生物
|
AU2013295594B2
(en)
|
2012-07-27 |
2018-03-29 |
Biogen Ma Inc. |
Compounds that are S1P modulating agents and/or ATX modulating agents
|
WO2014015523A1
(en)
|
2012-07-27 |
2014-01-30 |
Hutchison Medipharma Limited |
Novel heteroaryl and heterocycle compounds, compositions and methods
|
WO2014020152A1
(en)
|
2012-08-02 |
2014-02-06 |
Graffinity Pharmaceuticals Gmbh |
Ligands for apheresis and immunoabsorption
|
ES2666353T3
(es)
|
2012-09-06 |
2018-05-04 |
Bristol-Myers Squibb Company |
Inhibidores de JAK3 de imidazopiridazina y su uso para el tratamiento de enfermedades inflamatorias y autoinmunitarias
|
US10207989B2
(en)
|
2012-09-20 |
2019-02-19 |
Temple University—Of the Commonwealth System of Higher Education |
Substituted alkyl diaryl derivatives, methods of preparation and uses
|
UA110688C2
(uk)
|
2012-09-21 |
2016-01-25 |
Пфайзер Інк. |
Біциклічні піридинони
|
FR2997851B1
(fr)
|
2012-11-09 |
2014-11-28 |
Oreal |
Composition comprenant un derive dicarbonyle et procede de lissage des cheveux a partir de cette composition
|
US9757379B2
(en)
|
2012-11-14 |
2017-09-12 |
The Board Of Regents Of The University Of Texas System |
Inhibition of HIF-2α heterodimerization with HIF1β (ARNT)
|
RU2661896C2
(ru)
|
2012-11-16 |
2018-07-23 |
Мерк Шарп И Доум Корп. |
Пуриновые ингибиторы фосфатидилинозитол-3-киназы дельта человека
|
US9884886B2
(en)
|
2012-12-06 |
2018-02-06 |
Merck Sharp & Dohme |
Disulfide masked prodrug compositions and methods
|
JP2016508145A
(ja)
|
2013-01-08 |
2016-03-17 |
ザヴィラ ファーマシューティカルズ ゲーエムベーハー |
ピリドン誘導体及びウイルス性疾患の治療、改善又は予防におけるそれらの使用
|
US20140200215A1
(en)
|
2013-01-15 |
2014-07-17 |
Intermune, Inc. |
Lysophosphatidic acid receptor antagonists
|
KR102275616B1
(ko)
|
2013-01-29 |
2021-07-09 |
레드엑스 파마 피엘씨 |
연성 rock 저해제로서 피리딘 유도체
|
WO2014120820A1
(en)
*
|
2013-01-31 |
2014-08-07 |
Vertex Pharmaceuticals Incorporated |
Amides as modulators of sodium channels
|
TWI606048B
(zh)
|
2013-01-31 |
2017-11-21 |
帝人製藥股份有限公司 |
唑苯衍生物
|
UY35288A
(es)
|
2013-01-31 |
2014-08-29 |
Vertex Pharma |
Piridonamidas como moduladores de canales de sodio
|
EP2951168B1
(en)
|
2013-01-31 |
2017-01-04 |
Vertex Pharmaceuticals Incorporated |
Quinoline and quinoxaline amides as modulators of sodium channels
|
WO2014130856A2
(en)
|
2013-02-21 |
2014-08-28 |
Wayne Rothbaum |
Treatment of skeletal-related disorders
|
WO2014134127A1
(en)
|
2013-02-26 |
2014-09-04 |
Northeastern University |
Cannabinergic nitrate esters and related analogs
|
EP2970340B1
(en)
|
2013-03-14 |
2020-02-12 |
Venatorx Pharmaceuticals, Inc. |
Beta-lactamase inhibitors
|
WO2014179785A1
(en)
|
2013-05-03 |
2014-11-06 |
Inscent, Inc. |
Improved honeybee repellents and uses thereof
|
JP2014232188A
(ja)
|
2013-05-29 |
2014-12-11 |
コニカミノルタ株式会社 |
セルロースアシレートフィルム、円偏光板及び画像表示装置
|
TWI637949B
(zh)
|
2013-06-14 |
2018-10-11 |
塩野義製藥股份有限公司 |
胺基三衍生物及含有其等之醫藥組合物
|
TW201534597A
(zh)
|
2013-06-20 |
2015-09-16 |
Ab Science |
作為選擇性蛋白質激酶抑制劑之苯并咪唑衍生物
|
WO2015003723A1
(en)
|
2013-07-12 |
2015-01-15 |
Københavns Universitet |
Substituted 4-proline derivatives as iglur antagonists
|
JP6730183B2
(ja)
|
2013-07-12 |
2020-07-29 |
ヘルムホルツ−ツェントルム フュア インフェクツィオンスフォルシュンク ゲーエムベーハー |
シストバクトアミド(Cystobactamides)
|
WO2015003991A1
(en)
|
2013-07-12 |
2015-01-15 |
Syngenta Participations Ag |
Novel microbiocides
|
HUE037876T2
(hu)
|
2013-07-19 |
2018-09-28 |
Vertex Pharma |
Szulfonamidok mint nátriumcsatorna-modulátorok
|
AU2014295000A1
(en)
|
2013-07-25 |
2016-02-18 |
Fondazione Telethon |
Inhibitors of FAPP2 and uses thereof
|
EP3041470A4
(en)
|
2013-09-04 |
2017-05-03 |
Board Of Regents Of the University Of Texas System |
Methods and compositions for selective and targeted cancer therapy
|
EP3043803B1
(en)
|
2013-09-11 |
2022-04-27 |
Emory University |
Nucleotide and nucleoside compositions and their uses
|
KR101628288B1
(ko)
|
2013-09-30 |
2016-06-08 |
주식회사 엘지화학 |
음성 광학 분산도를 갖는 광학 소자 제조용 조성물 및 이로부터 제조된 광학 이방체
|
CA2925862A1
(en)
|
2013-10-01 |
2015-04-09 |
Glaxosmithkline Intellectual Property Development Limited |
Compounds for affinity chromatography and for extending the half-life of a therapeutic agent
|
US20160264614A1
(en)
|
2013-10-02 |
2016-09-15 |
Moderna Therapeutics, Inc. |
Polynucleotide molecules and uses thereof
|
WO2015054337A1
(en)
|
2013-10-09 |
2015-04-16 |
Emory University |
Heterocyclic coupling catalysts and methods related thereto
|
EP3663282B1
(en)
|
2013-12-03 |
2022-05-18 |
FMC Corporation |
Pyrrolidinone herbicides
|
WO2015085238A1
(en)
|
2013-12-05 |
2015-06-11 |
The Regents Of The University Of California, A California Corporation |
Inhibitors of lpxc
|
EP3053585A1
(en)
|
2013-12-13 |
2016-08-10 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
AP2016009287A0
(en)
|
2013-12-13 |
2016-06-30 |
Vertex Pharma |
Prodrugs of pyridone amides useful as modulators of sodium channels
|
US10131841B2
(en)
|
2013-12-16 |
2018-11-20 |
Merck Patent Gmbh |
Liquid-crystalline medium
|
MX2016008688A
(es)
|
2013-12-30 |
2017-01-12 |
Lifesci Pharmaceuticals Inc |
Compuestos terapéuticos inhibidores.
|
US9611252B2
(en)
|
2013-12-30 |
2017-04-04 |
Lifesci Pharmaceuticals, Inc. |
Therapeutic inhibitory compounds
|
WO2015157559A2
(en)
|
2014-04-09 |
2015-10-15 |
Siteone Therapeutics, Inc. |
10',11'-modified saxitoxins for the treatment of pain
|
WO2015162244A1
(en)
|
2014-04-25 |
2015-10-29 |
Basf Se |
N-acylamidine compounds
|
JP6295992B2
(ja)
|
2014-05-09 |
2018-03-20 |
信越化学工業株式会社 |
単量体の製造方法
|
US9701627B2
(en)
|
2014-06-16 |
2017-07-11 |
University Of Maryland, Baltimore |
LRRK2 GTP binding inhibitors for treatment of Parkinson's disease and neuroinflammatory disorders
|
WO2015196118A1
(en)
|
2014-06-19 |
2015-12-23 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
US20170175129A1
(en)
|
2014-06-19 |
2017-06-22 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
EP3157573A4
(en)
|
2014-06-19 |
2018-02-21 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
EP3164406A4
(en)
|
2014-07-01 |
2018-04-04 |
Rempex Pharmaceuticals, Inc. |
Boronic acid derivatives and therapeutic uses thereof
|
WO2016007837A1
(en)
|
2014-07-11 |
2016-01-14 |
Spero Therapeutics, Inc. |
Carbonyl linked bicyclic heteroaryl antibiotic tolerance inhibitors
|
MX2017000450A
(es)
|
2014-07-16 |
2017-08-16 |
Lifesci Pharmaceuticals Inc |
Compuestos terapeuticos inhibidores.
|
EP2977374A1
(en)
|
2014-07-21 |
2016-01-27 |
Université de Strasbourg |
Molecules presenting dual emission properties
|
EP2985334B1
(en)
|
2014-08-15 |
2018-06-20 |
Merck Patent GmbH |
Liquid-crystalline medium
|
US10913736B2
(en)
|
2014-08-22 |
2021-02-09 |
University Of Washington |
Specific inhibitors of methionyl-tRNA synthetase
|
MX2017002985A
(es)
|
2014-09-10 |
2017-11-17 |
Epizyme Inc |
Inhibidores de smyd.
|
WO2016040449A1
(en)
|
2014-09-10 |
2016-03-17 |
Raze Therapeutics, Inc. |
3-phosphoglycerate dehydrogenase inhibitors and uses thereof
|
JP2016079098A
(ja)
|
2014-10-10 |
2016-05-16 |
塩野義製薬株式会社 |
セフェム化合物
|
EP3215152A4
(en)
|
2014-11-05 |
2018-06-13 |
The University of Kansas |
SMALL MOLECULE INHIBITORS OF THE MITOCHONDRIAL PERMEABILITY TRANSITION PORE (mtPTP)
|
CN106998743B
(zh)
|
2014-12-10 |
2024-05-24 |
马斯公司 |
调节脂肪酸受体活性的化合物及包含该化合物的宠物食品
|
FR3030242B1
(fr)
|
2014-12-18 |
2018-01-26 |
L'oreal |
Emulsion contenant un tensioactif gemine ayant deux groupements amide gras et un filtre uv organique hydrosoluble
|
CN105985330A
(zh)
|
2015-02-04 |
2016-10-05 |
苏州旺山旺水生物医药有限公司 |
一类杂环化合物、其制备方法和用途
|
JP6394430B2
(ja)
|
2015-02-13 |
2018-09-26 |
信越化学工業株式会社 |
化合物、高分子化合物、レジスト材料及びパターン形成方法
|
WO2016145142A1
(en)
|
2015-03-10 |
2016-09-15 |
Emory University |
Nucleotide and nucleoside therapeutics compositions and uses related thereto
|
EP3085360A1
(en)
|
2015-04-20 |
2016-10-26 |
Universite De Bordeaux |
Lipid based nanocarrier compositions loaded with metal nanoparticles and therapeutic agent
|
US11040976B2
(en)
|
2015-04-24 |
2021-06-22 |
President And Fellows Of Harvard College |
Substrate selective inhibitors of insulin-degrading enzyme (IDE) and uses thereof
|
ES2761824T3
(es)
|
2015-05-15 |
2020-05-21 |
Gilead Sciences Inc |
Compuestos de carboximidamida de benzimidazol y imidazopiridina que tienen actividad como inhibidores de indoleamina 2,3-dioxigenasa
|
CA2983759A1
(en)
|
2015-06-02 |
2016-12-08 |
E I Du Pont De Nemours And Company |
Substituted cyclic amides and their use as herbicides
|
WO2016198908A1
(en)
|
2015-06-09 |
2016-12-15 |
Abbvie Inc. |
Ror nuclear receptor modulators
|
AU2016289413B2
(en)
|
2015-07-06 |
2020-03-26 |
Bayer Cropscience Aktiengesellschaft |
Nitrogenous heterocycles as a pesticide
|
MX2018000360A
(es)
|
2015-07-10 |
2018-06-11 |
Arvinas Inc |
Moduladores basados en mdm2 de proteolisis y metodos de uso asociados.
|
CN106518767A
(zh)
|
2015-09-11 |
2017-03-22 |
中国人民解放军军事医学科学院毒物药物研究所 |
取代苯并吡唑二芳基脲类化合物,其制备方法及其医药用途
|
CN106518766A
(zh)
|
2015-09-11 |
2017-03-22 |
中国人民解放军军事医学科学院毒物药物研究所 |
新型二芳基脲类化合物,其制备方法及其医药用途
|
WO2017051319A1
(en)
|
2015-09-21 |
2017-03-30 |
Glenmark Pharmaceuticals S.A. |
Aryl and heteroaryl ether compounds as ror gamma modulators
|
WO2017059385A1
(en)
|
2015-09-30 |
2017-04-06 |
Siteone Therapeutics, Inc. |
11,13-modified saxitoxins for the treatment of pain
|
WO2017059446A1
(en)
|
2015-10-01 |
2017-04-06 |
Memorial Sloan-Kettering Cancer Center |
Anthranilyl-adenosinemonosulfamate analogs and uses thereof
|
WO2017062751A1
(en)
|
2015-10-08 |
2017-04-13 |
The Regents Of The University Of California |
Compounds and methods for promoting stress resistance
|
US20180305334A1
(en)
|
2015-10-14 |
2018-10-25 |
Aquinnah Pharmaceuticals, Inc. |
Compounds, compositions and methods of use against stress granules
|
ES2914225T3
(es)
|
2015-10-16 |
2022-06-08 |
Modernatx Inc |
Análogos de cap de ARNm con enlace de fosfato modificado
|
WO2017066791A1
(en)
|
2015-10-16 |
2017-04-20 |
Modernatx, Inc. |
Sugar substituted mrna cap analogs
|
WO2017066782A1
(en)
|
2015-10-16 |
2017-04-20 |
Modernatx, Inc. |
Hydrophobic mrna cap analogs
|
ES2869229T3
(es)
|
2015-11-27 |
2021-10-25 |
Mitsubishi Tanabe Pharma Corp |
Derivados de 2-(((pirrolidin-3-il)carbonil)amino)-1H-imidazol como agonistas del receptor de melanocortina 1 (MCR1) para tratar la artritis reumatoide
|
GB201522232D0
(en)
|
2015-12-16 |
2016-01-27 |
Liverpool School Tropical Medicine |
Combination product
|
KR102606339B1
(ko)
|
2016-03-02 |
2023-11-24 |
삼성전자주식회사 |
유기금속 화합물 및 이를 포함한 유기 발광 소자
|
CN114539284A
(zh)
|
2016-03-16 |
2022-05-27 |
库拉肿瘤学公司 |
经取代的menin-mll抑制剂及使用方法
|
GB201604638D0
(en)
|
2016-03-18 |
2016-05-04 |
Mission Therapeutics Ltd |
Novel compounds
|
CA3019380A1
(en)
|
2016-03-31 |
2017-10-05 |
Vertex Pharmaceuticals Incorporated |
Modulators of cystic fibrosis transmembrane conductance regulator
|
CN105906591A
(zh)
|
2016-04-22 |
2016-08-31 |
中国药科大学 |
2-氨基-γ-丁内酯类盐酸盐的合成
|
TWI763668B
(zh)
*
|
2016-05-05 |
2022-05-11 |
美商嘉來克生命科學有限責任公司 |
整合應激途徑之調節劑
|
WO2017223260A1
(en)
|
2016-06-23 |
2017-12-28 |
Albert Einstein College Of Medicine, Inc. |
Pu.1 inhibitors
|
CN106220667B
(zh)
|
2016-07-21 |
2018-10-30 |
北京航空航天大学 |
螺环有机硅化合物及其应用
|
WO2018045106A1
(en)
|
2016-08-30 |
2018-03-08 |
Ohio State Innovation Foundation |
Anti-fungal treatment
|
WO2018055235A1
(en)
|
2016-09-21 |
2018-03-29 |
University Of Helsinki |
Isoxazole-amides for treating cardiac diseases
|
CA3038331A1
(en)
|
2016-09-28 |
2018-04-05 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof
|
WO2018060110A1
(en)
|
2016-09-28 |
2018-04-05 |
Merck Patent Gmbh |
Polymerisable liquid crystal material and polymerised liquid crystal film
|
US11179708B2
(en)
|
2016-10-04 |
2021-11-23 |
Massachusetts Institute Of Technology |
Compositions and methods for selective carbonylation of heterocyclic compounds
|
WO2018108083A1
(zh)
|
2016-12-12 |
2018-06-21 |
杭州英创医药科技有限公司 |
作为Syk抑制剂和/或Syk-HDAC双重抑制剂的杂环化合物
|
US20190388426A1
(en)
|
2017-01-30 |
2019-12-26 |
Université de Liège |
Perk and ire-1a inhibitors against neurodevelopmental disorders
|
WO2018161033A1
(en)
|
2017-03-02 |
2018-09-07 |
Wright, Adrian |
Small molecule ire1-alpha inhibitors
|
WO2018163077A1
(en)
*
|
2017-03-08 |
2018-09-13 |
Lupin Limited |
Indanyl compounds as voltage gated sodium channel modulators
|
CN108658972A
(zh)
|
2017-03-28 |
2018-10-16 |
中国海洋大学 |
一种取代内酰胺类化合物及其制备方法和用途
|
CN108658974A
(zh)
|
2017-03-28 |
2018-10-16 |
中国海洋大学 |
一种内酰胺类化合物及其制备方法和用途
|
CA3058214A1
(en)
|
2017-03-29 |
2018-10-04 |
Siteone Therapeutics, Inc. |
11,13-modified saxitoxins for the treatment of pain
|
CN110914276A
(zh)
|
2017-03-29 |
2020-03-24 |
赛特温治疗公司 |
用于治疗疼痛的11,13-修饰的石房蛤毒素类化合物
|
CA3058466A1
(en)
|
2017-03-30 |
2018-10-04 |
Shaw Industries Group, Inc. |
Carpet tiles and systems and methods of making same
|
CA3058639A1
(en)
|
2017-03-31 |
2018-10-04 |
Epizyme, Inc. |
Methods of using ehmt2 inhibitors
|
JP2020100564A
(ja)
|
2017-04-03 |
2020-07-02 |
京都薬品工業株式会社 |
リードスルー誘導剤およびその医薬用途
|
WO2018191146A1
(en)
|
2017-04-10 |
2018-10-18 |
Navitor Pharmaceuticals, Inc. |
Heteroaryl rheb inhibitors and uses thereof
|
CN108689942B
(zh)
|
2017-04-11 |
2023-06-09 |
广东东阳光药业有限公司 |
含氮双环化合物及其制备方法和用途
|
US11358940B2
(en)
|
2017-04-20 |
2022-06-14 |
The Regents Of The University Of California |
K-Ras modulators
|
AU2018254577B2
(en)
|
2017-04-21 |
2024-06-13 |
Epizyme, Inc. |
Combination therapies with EHMT2 inhibitors
|
ES2927712T3
(es)
|
2017-05-16 |
2022-11-10 |
Vertex Pharma |
Amidas deuteradas de piridona y profármacos de las mismas como moduladores de canales de sodio
|
CN107033149B
(zh)
|
2017-06-12 |
2020-01-03 |
上海交通大学 |
一种dpp-4酶抑制剂及其制备和应用
|
US11718638B2
(en)
|
2017-06-21 |
2023-08-08 |
Wave Life Sciences Ltd. |
Compounds, compositions and methods for synthesis
|
TW201920081A
(zh)
|
2017-07-11 |
2019-06-01 |
美商維泰克斯製藥公司 |
作為鈉通道調節劑的羧醯胺
|
CN109320509B
(zh)
|
2017-07-31 |
2022-02-08 |
轩竹生物科技股份有限公司 |
Fxr受体激动剂
|
CN109384712B
(zh)
|
2017-08-14 |
2021-05-07 |
北京宽厚医药科技有限公司 |
靶向nk1受体拮抗剂及其在化疗所致恶心、呕吐治疗中的应用
|
KR20200051646A
(ko)
|
2017-08-17 |
2020-05-13 |
이케나 온콜로지, 인코포레이티드 |
Ahr 억제제 및 이의 용도
|
US11795162B2
(en)
|
2017-08-18 |
2023-10-24 |
Saint Louis University |
Modulators of the estrogen-related receptor
|
CN109553608B
(zh)
|
2017-09-26 |
2020-12-08 |
北京大学 |
一类五元六元杂环化合物及其制备方法和治疗肿瘤的用途
|
IL310625A
(en)
|
2017-10-18 |
2024-04-01 |
Epizyme Inc |
Methods for using EHMT2 inhibitors in the treatment or prevention of blood disorders
|
CN111343989A
(zh)
|
2017-10-18 |
2020-06-26 |
Epizyme股份有限公司 |
使用ehmt2抑制剂用于免疫疗法的方法
|
US20210177827A1
(en)
|
2017-10-25 |
2021-06-17 |
Children`S Medical Center Corporation |
Papd5 inhibitors and methods of use thereof
|
EP3479843A1
(en)
|
2017-11-01 |
2019-05-08 |
GenKyoTex Suisse SA |
Use of nox inhibitors for treatment of cancer
|
TW201922690A
(zh)
|
2017-11-10 |
2019-06-16 |
中央研究院 |
環-amp反應元素結合蛋白的抑制劑
|
BR112020009729A2
(pt)
|
2017-11-15 |
2020-11-03 |
Metabomed Ltd. |
inibidores de acss2 e métodos de uso dos mesmos
|
EP3502684A1
(en)
|
2017-12-22 |
2019-06-26 |
Universite De Bordeaux |
Method for metal ion detection in aqueous solutions using nucleolipid compounds
|
KR20190076339A
(ko)
|
2017-12-22 |
2019-07-02 |
한미약품 주식회사 |
신규한 2,6-나프티리딘 2-옥시드 유도체 화합물 및 이의 용도
|
WO2019137201A1
(zh)
|
2018-01-09 |
2019-07-18 |
四川科伦博泰生物医药股份有限公司 |
杂芳基并四氢吡啶类化合物、其制备方法、药物组合物及应用
|
EA202091897A1
(ru)
|
2018-02-08 |
2020-10-27 |
Энио Фарма |
Неконденсированные производные тиофена и их применение
|
CA3091012A1
(en)
|
2018-02-12 |
2019-08-15 |
Vertex Pharmaceuticals Incorporated |
A method of treating pain
|
WO2019195439A1
(en)
|
2018-04-05 |
2019-10-10 |
St. Jude Medical, Cardiology Division, Inc. |
High density electrode mapping catheter
|
EP3784754B1
(en)
|
2018-04-27 |
2022-06-08 |
Merck Patent GmbH |
Polymerisable liquid crystal material and polymerised liquid crystal film
|
CN112041413A
(zh)
|
2018-04-27 |
2020-12-04 |
默克专利股份有限公司 |
可聚合的液晶材料和聚合的液晶膜
|
US20210221781A1
(en)
|
2018-05-16 |
2021-07-22 |
Lin Bioscience Pty Ltd. |
Fatty acid analogues and methods of use
|
TWI812739B
(zh)
|
2018-06-21 |
2023-08-21 |
景凱生物科技股份有限公司 |
Nadph氧化酶抑制劑、含其的醫藥組合物、及其應用
|
CA3105657A1
(en)
|
2018-07-09 |
2020-01-16 |
Lieber Institute, Inc. |
Pyridine carboxamide compounds for inhibiting nav1.8
|
SG11202100137TA
(en)
|
2018-07-09 |
2021-02-25 |
Lieber Institute Inc |
PYRIDAZINE COMPOUNDS FOR INHIBITING Nav1.8
|
CN112638899B
(zh)
|
2018-08-01 |
2023-09-05 |
上海轶诺药业有限公司 |
一类具有免疫调节功能的芳香化合物的制备和应用
|
US11945803B2
(en)
|
2018-08-07 |
2024-04-02 |
Tosk, Inc. |
Modulators of RAS GTPase
|
WO2020034058A1
(en)
|
2018-08-13 |
2020-02-20 |
Rhodia Operations |
PROCESS FOR REDUCTIVE AMINATION OF α,β-UNSATURATED CARBONYL COMPOUND
|
WO2020034062A1
(en)
|
2018-08-13 |
2020-02-20 |
Rhodia Operations |
Process for the reductive amination of a carbonyl compound
|
JP2021536458A
(ja)
|
2018-09-04 |
2021-12-27 |
マジェンタ セラピューティクス インコーポレイテッドMagenta Therapeutics, Inc. |
アリール炭化水素レセプター・アンタゴニスト及び使用方法
|
EP3856176A4
(en)
|
2018-09-28 |
2022-05-04 |
Acucela Inc. |
VAP-1 INHIBITORS
|
KR102092838B1
(ko)
|
2018-10-02 |
2020-03-24 |
성균관대학교산학협력단 |
신규 퓨란계 폴리카보네이트 및 이의 제조 방법
|
WO2020072835A1
(en)
|
2018-10-03 |
2020-04-09 |
Siteone Therapeutics, Inc. |
11,13-modified saxitoxins for the treatment of pain
|
TW202028183A
(zh)
|
2018-10-10 |
2020-08-01 |
大陸商江蘇豪森藥業集團有限公司 |
含氮雜芳類衍生物調節劑、其製備方法和應用
|
US20220402869A1
(en)
|
2018-10-15 |
2022-12-22 |
Dana-Farber Cancer Institute, Inc. |
Transcriptional enhanced associate domain (tead) transcription factor inhibitors and uses thereof
|
MY197128A
(en)
|
2018-11-02 |
2023-05-26 |
Merck Sharp & Dohme |
2-amino-n-heteroaryl-nicotinamides as nav1.8 inhibitors
|
WO2020092187A1
(en)
|
2018-11-02 |
2020-05-07 |
Merck Sharp & Dohme Corp. |
2-amino-n-phenyl-nicotinamides as nav1.8 inhibitors
|
KR102151855B1
(ko)
|
2018-11-30 |
2020-09-03 |
롯데케미칼 주식회사 |
공액 디엔계 및 방향족 비닐계 공중합체의 제조 방법 및 이로부터 제조된 공액 디엔계 및 방향족 비닐계의 공중합체를 포함하는 타이어
|
US20220023270A1
(en)
|
2018-12-06 |
2022-01-27 |
The Children's Medical Center Corporation |
Antibacterial compounds and uses thereof
|
WO2020123675A1
(en)
|
2018-12-11 |
2020-06-18 |
Duke University |
Compositions and methods for the treatment of cancer
|
WO2020146682A1
(en)
|
2019-01-10 |
2020-07-16 |
Vertex Pharmaceuticals Incorporated |
Carboxamides as modulators of sodium channels
|
US20220110923A1
(en)
|
2019-01-10 |
2022-04-14 |
Vertex Pharmaceuticals Incorporated |
Esters and carbamates as modulators of sodium channels
|
CN111434655A
(zh)
|
2019-01-15 |
2020-07-21 |
武汉朗来科技发展有限公司 |
溶血磷脂酸受体拮抗剂及其制备方法
|
EP3914669A1
(en)
|
2019-01-22 |
2021-12-01 |
Merck Patent GmbH |
Method for the preparation of a liquid crystal polymer film
|
WO2020159576A1
(en)
|
2019-01-28 |
2020-08-06 |
Mitochondria Emotion, Inc. |
Mitofusin activators and methods of use thereof
|
WO2020160225A1
(en)
|
2019-01-30 |
2020-08-06 |
Ohio State Innovation Foundation |
ESTROGEN RECEPTOR BETA (ERβ) AGONISTS FOR THE TREATMENT OF FIBROTIC CONDITIONS
|
WO2020191227A1
(en)
|
2019-03-20 |
2020-09-24 |
Cornell University |
Methods for controlling prostaglandin-mediated biological processes
|
WO2020191501A1
(en)
|
2019-03-27 |
2020-10-01 |
Algernon Pharmaceuticals Inc. |
Methods and uses of bemithyl and derivatives for treating lung disease, fatty liver disease, and kidney disorders
|
WO2020221677A1
(en)
|
2019-04-30 |
2020-11-05 |
Merck Patent Gmbh |
Reactive mesogens
|
US20220275009A1
(en)
|
2019-05-10 |
2022-09-01 |
Wacker Chemie Ag |
Cationic germanium(ii) compounds, process for preparing same, and their use as catalysts in hydrosilylation
|
CA3136083A1
(en)
|
2019-05-14 |
2020-11-19 |
Metabomed Ltd |
Acss2 inhibitors and methods of use thereof
|
WO2020251974A1
(en)
|
2019-06-10 |
2020-12-17 |
Kymera Therapeutics, Inc. |
Smarca inhibitors and uses thereof
|
WO2020254493A1
(en)
|
2019-06-21 |
2020-12-24 |
Bayer Aktiengesellschaft |
Thienylhydroxyisoxazolines and derivatives thereof
|
WO2021001739A1
(en)
|
2019-07-02 |
2021-01-07 |
Effector Therapeutics, Inc. |
Translational enhancers and related methods
|
CN112409331B
(zh)
|
2019-08-21 |
2024-02-20 |
上海翰森生物医药科技有限公司 |
杂环类衍生物抑制剂、其制备方法和应用
|
EP4045032A1
(en)
|
2019-10-17 |
2022-08-24 |
ENYO Pharma |
Thiophene derivatives for use in treating portal inflammation and fibrosis
|
CR20220316A
(es)
|
2019-12-06 |
2022-10-07 |
Vertex Pharma |
Tetrahidrofuranos sustituidos como moduladores de canales de sodio
|
EP4079295A4
(en)
|
2019-12-20 |
2023-12-06 |
Samyang Holdings Corporation |
COMPOSITION HAVING IMPROVED SOLUBILITY AND BIOAVAILABILITY OF OLAPARIB
|
JP2023529099A
(ja)
|
2020-05-28 |
2023-07-07 |
クルゲン(シャンハイ),インク. |
修飾タンパク質およびタンパク質分解誘導薬
|
GB202011996D0
(en)
|
2020-07-31 |
2020-09-16 |
Adorx Therapeutics Ltd |
Antagonist compounds
|
CN116194551A
(zh)
|
2020-09-24 |
2023-05-30 |
默克专利股份有限公司 |
可聚合液晶材料和聚合的液晶膜
|
WO2022070048A1
(en)
|
2020-09-29 |
2022-04-07 |
Cadila Healthcare Limited |
Novel amide derivatives
|
EP4232020A1
(en)
|
2020-10-21 |
2023-08-30 |
Kura Oncology, Inc. |
Treatment of hematological malignancies with inhibitors of menin
|
CN117794920A
(zh)
|
2021-06-04 |
2024-03-29 |
沃泰克斯药物股份有限公司 |
N-(羟烷基(杂)芳基)四氢呋喃甲酰胺作为钠通道调节剂
|